Award-winning actor and producer Sterling K. Brown joins Bristol-Myers Squibb in effort to share stories of What It's Like to Live with Cancer Today

Bristol-Myers SquibbTwo-time Emmy Award winner Sterling K. Brown (This Is Us, Black Panther) is partnering with Bristol-Myers Squibb on a series designed to illuminate the triumphs and challenges of life after a cancer diagnosis. Survivorship Today: What It's Like to Live with Cancer explores the stories of people who have experienced lasting physical, emotional and social effects from cancer to build greater understanding of, and draw attention to, survivorship-related issues.

Today, more people who have been diagnosed with cancer are able to live with the disease than ever before. During this time of rapid progress in cancer treatment, researchers are only just beginning to understand the long-term impacts of the disease on individuals and their loved ones. As the number of cancer survivors in the United States (U.S.) grows to nearly 17 million this year, it is increasingly important to recognize and address the current realities of cancer survivorship. Brown, who lost his uncle to cancer, is speaking with people around the country who have been impacted by the disease to find out what it's like to live with cancer today.

"When my uncle, Sonny, passed away from cancer just six months after his diagnosis, my entire family was devastated. Now, 15 years later, many people with cancer are living longer," said Brown. "While that means they might have a chance to celebrate another birthday or watch their children have children, it also means their lives have likely been forever changed. Survivorship Today will bring these experiences to light to show the long-term effects of cancer, with the goal of helping people feel supported every step of their journey."

Through the stories of people affected by cancer, the series will delve into topics such as:

  • Overcoming barriers: Some people who are diagnosed with cancer face a greater burden of the disease due to their unique circumstances, whether at home, at work or in their communities, which can affect them from diagnosis through treatment and beyond.
  • Impact on emotional and mental health: A person diagnosed with cancer is twice as likely to experience mental health problems compared to a person without the disease. These impacts can be even greater for individuals diagnosed as a young adult and can persist long after treatment ends.
  • Relationships afterward: Cancer touches all those who care about the person living with the disease. It deeply affects friends and family on emotional and physical levels as they do their best to support their loved one over time.

"Living long-term with cancer is a relatively new idea. We've made tremendous progress in addressing the disease itself, but we still need to answer the question of what comes next, outside of treatment," said Adam Lenkowsky, Head of U.S. Oncology, Bristol-Myers Squibb. "By bringing cancer survivorship into greater focus with this series, our goal is to help start a dialogue on the realities of living with cancer, so we can work together toward a day when all people with cancer can live longer, healthier lives and get the support they need."

Watch the series at SurvivorshipToday.com.

About Survivorship Today

Survivorship Today: What It's Like to Live with Cancer is an initiative by Bristol-Myers Squibb that, through the stories of people living with cancer, aims to advance our understanding of what it's like to live with the disease today and inspire action to provide better support.

About Cancer Survivorship

Cancer survivorship refers to the time from diagnosis throughout the remainder of a person’s life. There are nearly 17 million cancer survivors in the U.S. today. Over the next 10 years, this number is projected to increase to nearly 22 million. Today, more than 67 percent of people living with cancer have been alive for at least five years after their initial diagnosis, and more than 45 percent of people have been alive 10 years after diagnosis. However, many people living with cancer feel unprepared for life after active treatment.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Most Popular Now

Amgen and Allergan's MVASI™ (bevacizumab-awwb) and…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a bio...

Compound found in red wine opens door for new trea…

Like to unwind with a glass of red wine after a stressful day? Don't give alcohol all the credit. New research has revealed that the plant compound resveratrol, which is ...

HIV vaccine nears clinical trial following new fin…

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar p...

Mylan and Upjohn, a division of Pfizer, to combine…

HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer's o...

Leading oncologists and nutritionists pinpoint are…

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship betwe...

Closing the door: breaking new ground related to a…

In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid g...

Roche and Spark Therapeutics, Inc. announce extens…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") announced that Roche has extended the offering period of its previously announced...

FDA approves first generics of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associat...

FDA approves first treatment for severe hypoglycem…

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that c...

Rye is healthy, thanks to an interplay of microbes

Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribut...

GSK completes transaction with Pfizer to form new …

The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and Panadol and Pfizer's Advi...

Eating more plant-based foods may be linked to bet…

Eating mostly plant-based foods and fewer animal-based foods may be linked to better heart health and a lower risk of dying from a heart attack, stroke or other cardiovas...